Plasma-derived Therapies Market - Global Outlook and Forecast 2021-2027

April 2021 | 91 pages | ID: P8EC3C0D3416EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Plasma-derived Therapies in Global, including the following market information:

Global Plasma-derived Therapies Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Plasma-derived Therapies market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Plasma-derived Therapies companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Plasma-derived Therapies Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Plasma-derived Therapies Market Segment Percentages, By Type, 2020 (%)

• Albumin
• Immunoglobulin
• Factor VIII
• Others

China Plasma-derived Therapies Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Plasma-derived Therapies Market Segment Percentages, By Application, 2020 (%)

• Hemophilia
• Primary Immunodeficiencies (PIDs)
• Idiopathic Thrombocytopenic Purpura (ITP)
• COVID-19
• Others

Global Plasma-derived Therapies Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Plasma-derived Therapies Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Plasma-derived Therapies Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Plasma-derived Therapies Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• CSL Behring LLC
• Shire
• Bayer
• Kedrion
• Takeda
• Biotest
• Octaparma
• Bio Products Laboratory (BPL)
• LFB
• Grifols

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Angiotensin Converting Enzyme Inhibitors Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Angiotensin Converting Enzyme Inhibitors Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANGIOTENSIN CONVERTING ENZYME INHIBITORS OVERALL MARKET SIZE

2.1 Global Angiotensin Converting Enzyme Inhibitors Market Size: 2021 VS 2027
2.2 Global Angiotensin Converting Enzyme Inhibitors Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Angiotensin Converting Enzyme Inhibitors Players in Global Market
3.2 Top Global Angiotensin Converting Enzyme Inhibitors Companies Ranked by Revenue
3.3 Global Angiotensin Converting Enzyme Inhibitors Revenue by Companies
3.4 Top 3 and Top 5 Angiotensin Converting Enzyme Inhibitors Companies in Global Market, by Revenue in 2020
3.5 Global Companies Angiotensin Converting Enzyme Inhibitors Product Type
3.6 Tier 1, Tier 2 and Tier 3 Angiotensin Converting Enzyme Inhibitors Players in Global Market
  3.6.1 List of Global Tier 1 Angiotensin Converting Enzyme Inhibitors Companies
  3.6.2 List of Global Tier 2 and Tier 3 Angiotensin Converting Enzyme Inhibitors Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Angiotensin Converting Enzyme Inhibitors Market Size Markets, 2021 & 2027
  4.1.2 Benazepril (Lotensin)
  4.1.3 Captopril
  4.1.4 Enalapril (Vasotec)
  4.1.5 Fosinopril
  4.1.6 Lisinopril (Prinivil, Zestril)
  4.1.7 Moexipril
  4.1.8 Perindopril
  4.1.9 Quinapril (Accupril)
  4.1.10 Ramipril (Altace)
  4.2.11 Trandolapril
4.2 By Type - Global Angiotensin Converting Enzyme Inhibitors Revenue & Forecasts
  4.2.1 By Type - Global Angiotensin Converting Enzyme Inhibitors Revenue, 2016-2021
  4.2.2 By Type - Global Angiotensin Converting Enzyme Inhibitors Revenue, 2022-2027
  4.2.3 By Type - Global Angiotensin Converting Enzyme Inhibitors Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Angiotensin Converting Enzyme Inhibitors Market Size, 2021 & 2027
  5.1.2 Coronary Artery Disease
  5.1.3 Heart Failure
  5.1.4 Diabetes
  5.1.5 Chronic Kidney Diseases
  5.1.6 Heart Attacks
  5.1.7 Scleroderma
  5.1.8 Migraines
  5.1.9 Others
5.2 By Application - Global Angiotensin Converting Enzyme Inhibitors Revenue & Forecasts
  5.2.1 By Application - Global Angiotensin Converting Enzyme Inhibitors Revenue, 2016-2021
  5.2.2 By Application - Global Angiotensin Converting Enzyme Inhibitors Revenue, 2022-2027
  5.2.3 By Application - Global Angiotensin Converting Enzyme Inhibitors Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Angiotensin Converting Enzyme Inhibitors Market Size, 2021 & 2027
6.2 By Region - Global Angiotensin Converting Enzyme Inhibitors Revenue & Forecasts
  6.2.1 By Region - Global Angiotensin Converting Enzyme Inhibitors Revenue, 2016-2021
  6.2.2 By Region - Global Angiotensin Converting Enzyme Inhibitors Revenue, 2022-2027
  6.2.3 By Region - Global Angiotensin Converting Enzyme Inhibitors Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Angiotensin Converting Enzyme Inhibitors Revenue, 2016-2027
  6.3.2 US Angiotensin Converting Enzyme Inhibitors Market Size, 2016-2027
  6.3.3 Canada Angiotensin Converting Enzyme Inhibitors Market Size, 2016-2027
  6.3.4 Mexico Angiotensin Converting Enzyme Inhibitors Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Angiotensin Converting Enzyme Inhibitors Revenue, 2016-2027
  6.4.2 Germany Angiotensin Converting Enzyme Inhibitors Market Size, 2016-2027
  6.4.3 France Angiotensin Converting Enzyme Inhibitors Market Size, 2016-2027
  6.4.4 U.K. Angiotensin Converting Enzyme Inhibitors Market Size, 2016-2027
  6.4.5 Italy Angiotensin Converting Enzyme Inhibitors Market Size, 2016-2027
  6.4.6 Russia Angiotensin Converting Enzyme Inhibitors Market Size, 2016-2027
  6.4.7 Nordic Countries Angiotensin Converting Enzyme Inhibitors Market Size, 2016-2027
  6.4.8 Benelux Angiotensin Converting Enzyme Inhibitors Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Angiotensin Converting Enzyme Inhibitors Revenue, 2016-2027
  6.5.2 China Angiotensin Converting Enzyme Inhibitors Market Size, 2016-2027
  6.5.3 Japan Angiotensin Converting Enzyme Inhibitors Market Size, 2016-2027
  6.5.4 South Korea Angiotensin Converting Enzyme Inhibitors Market Size, 2016-2027
  6.5.5 Southeast Asia Angiotensin Converting Enzyme Inhibitors Market Size, 2016-2027
  6.5.6 India Angiotensin Converting Enzyme Inhibitors Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Angiotensin Converting Enzyme Inhibitors Revenue, 2016-2027
  6.6.2 Brazil Angiotensin Converting Enzyme Inhibitors Market Size, 2016-2027
  6.6.3 Argentina Angiotensin Converting Enzyme Inhibitors Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Angiotensin Converting Enzyme Inhibitors Revenue, 2016-2027
  6.7.2 Turkey Angiotensin Converting Enzyme Inhibitors Market Size, 2016-2027
  6.7.3 Israel Angiotensin Converting Enzyme Inhibitors Market Size, 2016-2027
  6.7.4 Saudi Arabia Angiotensin Converting Enzyme Inhibitors Market Size, 2016-2027
  6.7.5 UAE Angiotensin Converting Enzyme Inhibitors Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Pfizer
  7.1.1 Pfizer Corporate Summary
  7.1.2 Pfizer Business Overview
  7.1.3 Pfizer Angiotensin Converting Enzyme Inhibitors Major Product Offerings
  7.1.4 Pfizer Angiotensin Converting Enzyme Inhibitors Revenue in Global (2016-2021)
  7.1.5 Pfizer Key News
7.2 AstraZeneca
  7.2.1 AstraZeneca Corporate Summary
  7.2.2 AstraZeneca Business Overview
  7.2.3 AstraZeneca Angiotensin Converting Enzyme Inhibitors Major Product Offerings
  7.2.4 AstraZeneca Angiotensin Converting Enzyme Inhibitors Revenue in Global (2016-2021)
  7.2.5 AstraZeneca Key News
7.3 Novartis AG
  7.3.1 Novartis AG Corporate Summary
  7.3.2 Novartis AG Business Overview
  7.3.3 Novartis AG Angiotensin Converting Enzyme Inhibitors Major Product Offerings
  7.3.4 Novartis AG Angiotensin Converting Enzyme Inhibitors Revenue in Global (2016-2021)
  7.3.5 Novartis AG Key News
7.4 Daiichi Sankyo, Inc
  7.4.1 Daiichi Sankyo, Inc Corporate Summary
  7.4.2 Daiichi Sankyo, Inc Business Overview
  7.4.3 Daiichi Sankyo, Inc Angiotensin Converting Enzyme Inhibitors Major Product Offerings
  7.4.4 Daiichi Sankyo, Inc Angiotensin Converting Enzyme Inhibitors Revenue in Global (2016-2021)
  7.4.5 Daiichi Sankyo, Inc Key News
7.5 Sanofi
  7.5.1 Sanofi Corporate Summary
  7.5.2 Sanofi Business Overview
  7.5.3 Sanofi Angiotensin Converting Enzyme Inhibitors Major Product Offerings
  7.5.4 Sanofi Angiotensin Converting Enzyme Inhibitors Revenue in Global (2016-2021)
  7.5.5 Sanofi Key News
7.6 Merck
  7.6.1 Merck Corporate Summary
  7.6.2 Merck Business Overview
  7.6.3 Merck Angiotensin Converting Enzyme Inhibitors Major Product Offerings
  7.6.4 Merck Angiotensin Converting Enzyme Inhibitors Revenue in Global (2016-2021)
  7.6.5 Merck Key News
7.7 Abbott
  7.7.1 Abbott Corporate Summary
  7.7.2 Abbott Business Overview
  7.7.3 Abbott Angiotensin Converting Enzyme Inhibitors Major Product Offerings
  7.4.4 Abbott Angiotensin Converting Enzyme Inhibitors Revenue in Global (2016-2021)
  7.7.5 Abbott Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Plasma-derived Therapies Market Opportunities & Trends in Global Market
Table 2. Plasma-derived Therapies Market Drivers in Global Market
Table 3. Plasma-derived Therapies Market Restraints in Global Market
Table 4. Key Players of Plasma-derived Therapies in Global Market
Table 5. Top Plasma-derived Therapies Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Plasma-derived Therapies Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Plasma-derived Therapies Revenue Share by Companies, 2016-2021
Table 8. Global Companies Plasma-derived Therapies Product Type
Table 9. List of Global Tier 1 Plasma-derived Therapies Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Plasma-derived Therapies Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Plasma-derived Therapies Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Plasma-derived Therapies Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Plasma-derived Therapies Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Plasma-derived Therapies Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Plasma-derived Therapies Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Plasma-derived Therapies Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Plasma-derived Therapies Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Plasma-derived Therapies Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Plasma-derived Therapies Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Plasma-derived Therapies Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Plasma-derived Therapies Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Plasma-derived Therapies Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Plasma-derived Therapies Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Plasma-derived Therapies Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Plasma-derived Therapies Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Plasma-derived Therapies Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Plasma-derived Therapies Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Plasma-derived Therapies Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Plasma-derived Therapies Revenue, (US$, Mn), 2022-2027
Table 30. CSL Behring LLC Corporate Summary
Table 31. CSL Behring LLC Plasma-derived Therapies Product Offerings
Table 32. CSL Behring LLC Plasma-derived Therapies Revenue (US$, Mn), (2016-2021)
Table 33. Shire Corporate Summary
Table 34. Shire Plasma-derived Therapies Product Offerings
Table 35. Shire Plasma-derived Therapies Revenue (US$, Mn), (2016-2021)
Table 36. Bayer Corporate Summary
Table 37. Bayer Plasma-derived Therapies Product Offerings
Table 38. Bayer Plasma-derived Therapies Revenue (US$, Mn), (2016-2021)
Table 39. Kedrion Corporate Summary
Table 40. Kedrion Plasma-derived Therapies Product Offerings
Table 41. Kedrion Plasma-derived Therapies Revenue (US$, Mn), (2016-2021)
Table 42. Takeda Corporate Summary
Table 43. Takeda Plasma-derived Therapies Product Offerings
Table 44. Takeda Plasma-derived Therapies Revenue (US$, Mn), (2016-2021)
Table 45. Biotest Corporate Summary
Table 46. Biotest Plasma-derived Therapies Product Offerings
Table 47. Biotest Plasma-derived Therapies Revenue (US$, Mn), (2016-2021)
Table 48. Octaparma Corporate Summary
Table 49. Octaparma Plasma-derived Therapies Product Offerings
Table 50. Octaparma Plasma-derived Therapies Revenue (US$, Mn), (2016-2021)
Table 51. Bio Products Laboratory (BPL) Corporate Summary
Table 52. Bio Products Laboratory (BPL) Plasma-derived Therapies Product Offerings
Table 53. Bio Products Laboratory (BPL) Plasma-derived Therapies Revenue (US$, Mn), (2016-2021)
Table 54. LFB Corporate Summary
Table 55. LFB Plasma-derived Therapies Product Offerings
Table 56. LFB Plasma-derived Therapies Revenue (US$, Mn), (2016-2021)
Table 57. Grifols Corporate Summary
Table 58. Grifols Plasma-derived Therapies Product Offerings
Table 59. Grifols Plasma-derived Therapies Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Plasma-derived Therapies Segment by Type
Figure 2. Plasma-derived Therapies Segment by Application
Figure 3. Global Plasma-derived Therapies Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Plasma-derived Therapies Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Plasma-derived Therapies Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Plasma-derived Therapies Revenue in 2020
Figure 8. By Type - Global Plasma-derived Therapies Revenue Market Share, 2016-2027
Figure 9. By Application - Global Plasma-derived Therapies Revenue Market Share, 2016-2027
Figure 10. By Region - Global Plasma-derived Therapies Revenue Market Share, 2016-2027
Figure 11. By Country - North America Plasma-derived Therapies Revenue Market Share, 2016-2027
Figure 12. US Plasma-derived Therapies Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Plasma-derived Therapies Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Plasma-derived Therapies Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Plasma-derived Therapies Revenue Market Share, 2016-2027
Figure 16. Germany Plasma-derived Therapies Revenue, (US$, Mn), 2016-2027
Figure 17. France Plasma-derived Therapies Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Plasma-derived Therapies Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Plasma-derived Therapies Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Plasma-derived Therapies Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Plasma-derived Therapies Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Plasma-derived Therapies Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Plasma-derived Therapies Revenue Market Share, 2016-2027
Figure 24. China Plasma-derived Therapies Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Plasma-derived Therapies Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Plasma-derived Therapies Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Plasma-derived Therapies Revenue, (US$, Mn), 2016-2027
Figure 28. India Plasma-derived Therapies Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Plasma-derived Therapies Revenue Market Share, 2016-2027
Figure 30. Brazil Plasma-derived Therapies Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Plasma-derived Therapies Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Plasma-derived Therapies Revenue Market Share, 2016-2027
Figure 33. Turkey Plasma-derived Therapies Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Plasma-derived Therapies Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Plasma-derived Therapies Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Plasma-derived Therapies Revenue, (US$, Mn), 2016-2027
Figure 37. CSL Behring LLC Plasma-derived Therapies Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Shire Plasma-derived Therapies Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Bayer Plasma-derived Therapies Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Kedrion Plasma-derived Therapies Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Takeda Plasma-derived Therapies Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Biotest Plasma-derived Therapies Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Octaparma Plasma-derived Therapies Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Bio Products Laboratory (BPL) Plasma-derived Therapies Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. LFB Plasma-derived Therapies Revenue Year Over Year Growth (US$, Mn) & (2016-2021)